DIS stock · GANX stock

DIS vs GANX · P/E 16, rev $94.42B vs $53.0M cap

Walt Disney Company (DIS) versus Gain Therapeutics Inc (GANX) — a side-by-side from cached financials, not a winner call.

Walt Disney Company (DIS) is a entertainment company listed on NYSE. It is led by Josh D'Amaro.

Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.

Latest reported DIS revenue for 2025-09-27 was $94.42B. Net income was $12.40B. DIS currently screens at market cap $175.14B and trailing P/E 16.1.

GANX does not have a complete income-statement cache yet.

DIS currently screens at market cap $175.14B and trailing P/E 16.1. GANX currently screens at market cap $53.0M.

Not investment advice. Open the DIS and GANX stock pages for the full models.

Not investment advice.

Popular Stock Comparisons